Bristol Myers Squibb (BMY) Gross Margin Growth (5y) (2014 - 2026)

Bristol Myers Squibb (BMY) Gross Margin Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -412.00
Dec 31, 2025 -648.00
Sep 30, 2025 -437.00
Jun 30, 2025 -84.00
Mar 31, 2025 689.00
Dec 31, 2024 -762.00
Sep 30, 2024 493.00
Jun 30, 2024 466.00
Mar 31, 2024 610.00
Dec 31, 2023 304.00
Sep 30, 2023 611.00
Jun 30, 2023 287.00
Mar 31, 2023 787.00
Dec 31, 2022 665.00
Sep 30, 2022 908.00
Jun 30, 2022 762.00
Mar 31, 2022 445.00
Dec 31, 2021 716.00
Sep 30, 2021 680.00
Jun 30, 2021 381.00